In addition, ZEB2 protects bladder cancer and squamous carcinoma cells from cisplatin- and ultraviolet-induced apoptosis, and this pro-survival effect of ZEB2 is independent on ZEB2-mediated EMT induction and cell cycle arrest [10, 11]. The gene discussed is ZEB2; the disease is urinary bladder carcinoma.